Aethlon Medical
AEMD
24 hedge funds and large institutions have $2.83M invested in Aethlon Medical in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
33% more funds holding
Funds holding: 18 → 24 (+6)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
32% less capital invested
Capital invested by funds: $4.18M → $2.83M (-$1.34M)
75% less call options, than puts
Call options by funds: $51K | Put options by funds: $200K
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$547K |
| 2 |
Two Sigma Investments
New York
|
+$205K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$137K |
| 4 |
Two Sigma Advisers
New York
|
+$121K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$102K |
Top Sellers
| 1 |
Jane Street
New York
|
-$101K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$91.1K |
| 3 |
CG
Cutler Group
San Francisco,
California
|
-$4.55K |
| 4 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$4K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$2.28K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Jane Street
New York
| – | -$101K | -33 | Closed |
|
|
HI
27
Harbour Investments
Madison,
Wisconsin
| – | -$4K | -1 | Closed |
|
AEMD Hedge Fund Activity: Q4 2021 in Review
24 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q4 2021, worth a combined $2.83M — down 32% from $4.18M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new AEMD positions and 2 closed out — a net gain of 6 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $547K. The largest seller was Jane Street, exiting entirely with an estimated $101K sold.
- 24 institutional investors held Aethlon Medical (AEMD) as of Q4 2021, up from 18 in Q3 2021.
- Funds reported $2.83M of Aethlon Medical stock for Q4 2021, down 32% quarter-over-quarter.
- 8 funds opened new Aethlon Medical positions in Q4 2021 and 2 closed out, a net change of +6 holders.
- The largest Aethlon Medical buyer in Q4 2021 was Renaissance Technologies, an estimated $547K added.
- The largest Aethlon Medical seller in Q4 2021 was Jane Street, an estimated $101K sold.
Based on aggregated 13F filings for Q4 2021.